Accord Healthcare, Inc. has issued a consumer-level, nationwide recall of a single lot (PW05264) of mislabeled hydrochlorothiazide 12.5 mg tablets, per U.S. Food and Drug Administration (FDA). It was discovered, through a patient complaint, that a 100-count bottle hydrochlorothiazide contains 100 spironolactone 25 mg tablets.
Similar to hydrochlorothiazide, spironolactone is also used as a blood pressure drug. However, the use of spironolactone could increase potassium levels, which could be fatal for some patients. It could even cause arrhythmia when taken in larger doses. It is also used to treat liver, heart and kidney failure, according to the FDA. Aldactone and CaroSpir are the brand names that spironolactone is sold in, per NBC News.
As of now, there are no reports of patients getting sick because of this mishap.
Accord believes that no other lots of hydrochlorothiazide have been affected by the mislabeling, however, it asks consumers to be more cautious especially if this drug is prescribed to them. The company also calls for wholesalers and distributors to halt the distribution of this drug and immediately notify their customers.
For guidance, FDA also included this description of the drug in its announcement: “Accord’s Hydrochlorothiazide Tablets USP 12.5 mg are light orange to peach colored, round, biconvex tablets debossed with H on one side and 1 on another side.”
Accord also encourages both consumers and distributors to contact them about this recall during business hours—Monday through Friday 8 a.m. to 5 p.m. EST. You can reach them by:
- phone: at 1-855-869-1081
- fax: 1-817-868-5362
- e-mail: firstname.lastname@example.org
Accord Healthcare, Inc. is a generic pharmaceutical company that develops and manufactures products for different areas of medicine. It serves consumers from North America, Europe, South America, Australia, New Zealand, South Africa and the MENA region.
Extended reality is the future, and Zadar Ventures Ltd. is at the forefront
Emerging technologies are in the spotlight at the height of COVID-19. From drones to telemedicine to extended reality, the pandemic...
Small biotech companies have also entered the race to find a vaccine against COVID-19
An impressive number of biotech companies have entered the race to find a vaccine that would put an end to...
Cannabis stocks take a beating in a tough context
The difficult economic context generated by the coronavirus crisis has taken its toll on cannabis shares. Just like other sectors,...
B2B spending with virtual cards expected to skyrocket
The latest research conducted by Juniper, shows that there will be an impressive increase in the use of virtual payment...
The debt is ticking in the background like a bomb ready to explode
If someone in 2019 had said 2020 will be like this, they’d have thought you were delusional, super pessimistic, or...
Crowdfunding7 days ago
The real estate lending crowdfunding portal Trusters launches a round of €1 million
Crypto6 days ago
How governments are analyzing Crypto and Blockchains
Featured7 days ago
Credimi and Banca Generali partner to help SMEs in Italy
Biotech7 days ago
Foren Method seeks €2 million to finance its clinical trial